Rapifen, Injektions-/Infusionslösung

7680452040149 CH-45204 Ampullen
Rapifen, Injektions-/Infusionslösung
Rapifen, Injektions-/Infusionslösung
Rapifen, Injektions-/Infusionslösung
1 / 3
google

Article details

Package size
5 x 2 ml
Selling units
5
Measure
Ampulle(n)
Galenic form
Ampullen
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
04/09/2024
Summary of Product Characteristics
Français
04/09/2024
Summary of Product Characteristics
Italien
04/09/2024

Detailed composition

Substance Quantity Type Category
(N/A)
0.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.54 MG Substance HBESI

Authorization holder

Piramal Critical Care Limited,

8803 Rüschlikon

Authorization information

Swissmedic authorization number
45204
Drug name
Rapifen, Injektions-/Infusionslösung
Galenic form
LSIN
ATC Code
N01AH02
Authorization status
Z
Dispensing category
A+
First authorization
12/08/1983
Authorization expiration date
31/12/9999
IT Number
01.01.3.
Domain
Human medicine
Field of application
Narco-Analgeticum zur Anästhesie

Package details

Description (FR)
RAPIFEN sol inj 1 mg/2ml 5 amp 2 ml
Description (DE)
RAPIFEN Inj Lös 1 mg/2ml 5 Amp 2 ml
Market launch
12/08/1983
Narcotic (BTM)
A

Other package sizes (3)

None
10 x 2 ml AMP
GTIN: None
Not in V1
None
10 x 10 ml AMP
GTIN: None
Not in V1
RAPIFEN sol inj 5 mg/10ml 50 amp 10 ml
50 x 10 ml AMP
GTIN: 7680452040491
View